Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL494161 (Ro-51) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
P2X3/P2X2/P2X2/P2X3 heterotrimeric receptor in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3831281] [GtoPdb: 480, 479] [UniProtKB: P56373, Q9UBL9] | ||||||||
ChEMBL | Antagonist activity against human P2X2/3 receptor expressed in CHOK1 cells assessed as inhibition of alpha,beta-meATP-induced calcium response incubated for 20 mins by Fluo-3AM dye based FLIPR assay | F | 8.1 | pKi | 7.94 | nM | Ki | US-20080207655-A1. Diaminopyrimidines as P2X3 and P2X2/3 modulators (2008) |
ChEMBL | Antagonist activity at human P2X2/3 receptor | B | 7.35 | pIC50 | 44.9 | nM | IC50 | Bioorg Med Chem Lett (2021) 37: 127833-127833 [PMID:33540044] |
ChEMBL | Antagonist activity at human P2X2/3 receptor expressed in 1321n1c cells by FLIPR | F | 8.3 | pIC50 | 5.01 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1632-1635 [PMID:19231178] |
GtoPdb | - | - | 8.9 | pIC50 | - | - | - | Neuropharmacology (2016) 104: 31-49 [PMID:26686393] |
P2X1/P2X purinoceptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2094] [GtoPdb: 478] [UniProtKB: P51575] | ||||||||
ChEMBL | Antagonist activity at P2X1 receptor up to 10 uM | F | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1632-1635 [PMID:19231178] |
ChEMBL | Antagonist activity at human P2X1 receptor expressed in rat C6-BU-1 cells | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2021) 37: 127833-127833 [PMID:33540044] |
P2X2/P2X purinoceptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2531] [GtoPdb: 479] [UniProtKB: Q9UBL9] | ||||||||
ChEMBL | Antagonist activity at P2X2 receptor up to 10 uM | F | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1632-1635 [PMID:19231178] |
ChEMBL | Antagonist activity at human P2X2 receptor expressed in rat C6-BU-1 cells | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2021) 37: 127833-127833 [PMID:33540044] |
P2X3/P2X purinoceptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2998] [GtoPdb: 480] [UniProtKB: P56373] | ||||||||
ChEMBL | Antagonist activity at human P2X3 receptor expressed in rat C6-BU-1 cells | B | 8.2 | pIC50 | 6.3 | nM | IC50 | Bioorg Med Chem Lett (2021) 37: 127833-127833 [PMID:33540044] |
GtoPdb | - | - | 8.9 | pIC50 | - | - | - | Neuropharmacology (2016) 104: 31-49 [PMID:26686393] |
P2X3/P2X purinoceptor 3 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4824] [GtoPdb: 480] [UniProtKB: P49654] | ||||||||
ChEMBL | Antagonist activity against rat P2X3 receptor expressed in CHOK1 cells assessed as inhibition of alpha,beta-meATP-induced calcium response incubated for 20 mins by Fluo-3AM dye based FLIPR assay | F | 8.53 | pKi | 2.95 | nM | Ki | US-20080207655-A1. Diaminopyrimidines as P2X3 and P2X2/3 modulators (2008) |
ChEMBL | Antagonist activity at rat P2X3 receptor expressed in CHO cells by FLIPR | F | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1632-1635 [PMID:19231178] |
P2X4/P2X purinoceptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2104] [GtoPdb: 481] [UniProtKB: Q99571] | ||||||||
ChEMBL | Antagonist activity at P2X4 receptor up to 10 uM | F | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1632-1635 [PMID:19231178] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in rat C6-BU-1 cells | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2021) 37: 127833-127833 [PMID:33540044] |
P2X5/P2X purinoceptor 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4942] [GtoPdb: 482] [UniProtKB: Q93086] | ||||||||
ChEMBL | Antagonist activity at P2X5 receptor up to 10 uM | F | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1632-1635 [PMID:19231178] |
P2X7/P2X purinoceptor 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4805] [GtoPdb: 484] [UniProtKB: Q99572] | ||||||||
ChEMBL | Antagonist activity at P2X7 receptor up to 10 uM | F | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 1632-1635 [PMID:19231178] |
ChEMBL | Antagonist activity at human P2X7 receptor expressed in HEK293 cells | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2021) 37: 127833-127833 [PMID:33540044] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]